Vogenx Inc. (VOGX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Vogenx Inc. (VOGX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $239.2M, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.00 to the broader market. Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. Led by James Green, public since 2026-08-12.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for VOGX as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →